Rare disease patient groups as clinical researchers
- 1 February 2012
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 17 (3-4) , 167-172
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The role of patient advocacy organisations in neuromuscular disease R&D – The case of the Dutch neuromuscular disease association VSNNeuromuscular Disorders, 2010
- Clinical research for rare disease: Opportunities, challenges, and solutionsMolecular Genetics and Metabolism, 2009
- Empowerment of patients: lessons from the rare diseases communityThe Lancet, 2008
- A journey of hope: lessons learned from studies on rare diseases and orphan drugsJournal of Internal Medicine, 2006
- What I've Learned from E-PatientsPLOS Medicine, 2005
- The experiential knowledge of patients: a new resource for biomedical research?Social Science & Medicine, 2005
- The first generation of e-patientsBMJ, 2004
- The struggle against neuromuscular diseases in France and the emergence of the “partnership model” of patient organisationSocial Science & Medicine, 2003
- Research “in the wild” and the shaping of new social identitiesTechnology in Society, 2003
- The involvement of patients' associations in researchInternational Social Science Journal, 2002